Rod A. Humerickhouse, MD, PhD Group Project Leader, Oncology Development, AbbVie, discusses Recent Advancements In The Treatment Of CLL. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Rod A. Humerickhouse, MD, PhD Group Project Leader, Oncology Development, AbbVie, discusses Recent Advancements In The Treatment Of CLL. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com